Company
Headquarters: Shanghai, China
Employees: 1,301
CN¥3.61 Billion
CNY as of Jan. 1, 2025
US$494.5 Million
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Merck | $244.44 B |
Roche | $219.35 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, tonic products, cold and cough, children's medicine, and anti-fungal drugs. Its products include prescription drugs and OTC products. The company was founded in 1992 and is based in Shanghai, China.
Shanghai Shenqi Pharmaceutical Investment Management Co.,Ltd. has the following listings and related stock indices.
Stock: SSE: 600613 wb_incandescent
Stock: SSE: 900904 wb_incandescent